-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
recently, a large long-term study in London, England, showed that people with high blood pressure want to prevent heart attacks, while taking antihypertensive drugs and statins (drugs that help regulate cholesterol levels) may be the best option.
Ajay Gupta, a researcher at the William Harvey Institute at Queen Mary University of London, presented the findings at this year's annual meeting of the European Society of Cardiology and published them in
paper.
" 65-year-olds with high blood pressure are less likely to die of a heart attack or stroke between the ages of 75 and 80 if they are treated with both blood pressure-lowering medications based on calcium channel blockers and statins. Dr. Ajay Gupta explains.
study looked at the effectiveness of different treatments in controlling cardiovascular disease, according to the study. The researchers continued the work of the original ASCOT from the British-Scandinavian Cardiac Prognosmation Test (ASCOT) legacy study and came up with their results.
new study, researchers tracked 8,580 British subjects recruited between 1998 and 2000, all of them with high blood pressure.
According to ASCOT data, Dr Gupta and his team found that patients with high blood pressure who had been on the drug 5.5 years of acetaminophen and pyridoxine were 29 percent less likely to die from stroke after 10 years than those who received traditional antihypertensive drugs.
. Also, patients with high blood pressure with normal cholesterol levels (an average of 6.5 millimoles per litre) took statins and had a 15 percent lower risk of dying from heart disease and stroke after 16 years than those who took only a placebo.
addition, patients with "double height" were 21 percent less likely to die from cardiovascular disease within 10 years through blood pressure-lowering therapy (ammonia chlorpyrine and pepri) and routine cholesterol-lowering therapy.
" results are remarkable. We've shown before that statins can have long-term survival benefits, but this is the first time they've been used to lower blood pressure. Professor Mark Caulfield, director of the William Harvey Institute, also stressed the importance of the study for preventive medicine. This study confirms the importance of lowering blood pressure and cholesterol, which can be used to prevent disability and fatal cardiovascular disease. (Source: Wang Fei, China Science Daily)